Log In
BCIQ
Print this Print this
 

Danegaptide (ZP1609) (formerly GAP-134)

  Manage Alerts
Collapse Summary General Information
Company Zealand Pharma A/S
DescriptionOrally available gap junction modifier
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$0.2M

$0.2M

0


 Deals Details
Get a free BioCentury trial today